Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Lung Cancer
71%
Lung Tumor
68%
Carcinogenesis
42%
Protein P53
34%
Malignant Neoplasm
33%
Mouse Model
25%
A J Mouse
22%
Carcinogen
20%
Lung Adenocarcinoma
18%
Epidermal Growth Factor Receptor
15%
Tumor Growth
15%
Lung Carcinogenesis
13%
Chemopreventive Agents
12%
Bexarotene
12%
Transgenic Mouse
11%
Cancer Susceptibility
10%
Squamous Cell Lung Carcinoma
10%
Breast Cancer
9%
Non Small Cell Lung Cancer
9%
Tumor Suppressor Protein
9%
Biological Marker
9%
Polyphenon E
9%
4 (Methylnitrosamino) 1 (3 Pyridyl) 1 Butanone
9%
N-Nitroso-N-Methylurea
9%
Tumor Model
8%
Protein Farnesyltransferase Inhibitor
8%
Bladder Cancer
8%
Honokiol
8%
Diseases
7%
Lung Adenoma
7%
Budesonide
7%
Benzo(a)pyrene
7%
Pioglitazone
7%
Mouse Mutant
6%
Pharmacokinetic
6%
microRNA
6%
Tipifarnib
6%
Nicotine-Derived Nitrosamine Ketone
6%
Messenger RNA
6%
Bladder Tumor
6%
Gefitinib
6%
Liver Tumor
6%
Cigarette Smoke
6%
Wild Type Mouse
5%
Nitrosourea
5%
Adenocarcinoma
5%
Aromatase Inhibitor
5%
Vorozole
5%
Biochemistry, Genetics and Molecular Biology
Carcinogenesis
46%
Allele
25%
Tumor Suppressor Gene
19%
Gene Expression
17%
P53
14%
Loss of Heterozygosity
14%
Genetics
13%
Programmed Cell Death
13%
Oncogene Ras
12%
Single-Nucleotide Polymorphism
11%
Candidate Gene
11%
Messenger RNA
11%
Gene Expression Profiling
10%
Oncogene
10%
Quantitative Trait Locus
10%
Tumor Progression
10%
Genome-Wide Association Study
10%
Smoking
10%
Inbred Mouse Strain
9%
P16
9%
Genomics
8%
Genetic Divergence
8%
Bagg Albino Mouse
8%
Haplotype
8%
MicroRNA
8%
Gene Mutation
8%
Chromosome 4
8%
A J Mouse
7%
Genotyping
7%
Wild Type
7%
Epidermal Growth Factor Receptor
7%
Cell Cycle
6%
Tumor Suppressor Protein
6%
Linkage Analysis
6%
Gene Linkage
6%
Chromosome 18
6%
Exon
6%
Farnesyltransferase
6%
DNA Library
6%
Cancer Cell
5%
DNA Microarray
5%
Hybrid Mouse Strain
5%
Germline Mutation
5%
Upregulation
5%
CHRNA5
5%
Genetic Susceptibility
5%
Proto Oncogene
5%
Cell Proliferation
5%
Methylation
5%
Genome Wide Association Study
5%
Keyphrases
Lung Tumor
36%
Tumor
24%
KRAS mutation
22%
Lung Tumorigenesis
18%
Chemopreventive
17%
Mouse Lung Tumors
16%
Lung Cancer
15%
Lung Carcinogenesis
13%
Mouse Lung
12%
K-ras
12%
Oncogene
10%
Mouse Model
10%
Tumor Susceptibility
8%
Tumor Progression
8%
Farnesyltransferase Inhibitor
8%
Transgenic Mice
8%
Loss of Heterozygosity
7%
Tumor multiplicity
7%
Dominant Negative
7%
Lung Tissue
6%
Allelic Loss
6%
Ink4a
6%
P16INK4a
6%
Lung Adenocarcinoma
6%
Budesonide
6%
N-ethyl-N-nitrosourea
6%
TP53 mutation
5%
Lung
5%
Adenocarcinoma
5%
Chemically Induced
5%
Lung Cancer Risk
5%
Differentially Expressed
5%
Tumor Suppressor Gene
5%
